Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2
- PMID: 14635115
- DOI: 10.1002/humu.9200
Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2
Abstract
Primary hyperoxaluria type 2, an inherited autosomal recessive disorder of endogenous oxalate overproduction, is caused by mutations in the GRHPR gene encoding the glyoxylate/hydroxypyruvate reductase enzyme. The GRHPR genes from nineteen unrelated patients with PH2 were analysed for mutations using a combination of PCR-SSCP and sequence analysis of genomic and cDNA. Eleven mutations were identified, seven of which are novel. The mutations included five point mutations: c.84-2A>G, c.295C>T (R99X), c.494G>A (G165D), and c.904C>T (R302C) as well as six minor deletions: c.103delG, c.375delG, c.403_405+2 delAAGT, c.540delT, c.608_609delCT and a more complex mutation in intron 1: c.84-13_c.84-12del; c.84-8_c.84-5del. Aberrant transcripts were demonstrated in hepatic mRNA as a result of the c.403_405+2 delAAGT and c.84-2A>G mutations. In addition, a splice variant lacking 28 bp of exon 1 was expressed in a number of tissues but is of unknown function. Two polymorphisms, c.579A>G in exon 6 and a (CT)(n) microsatellite in intron 8 were identified. Expression studies showed that the G165D and R302C mutants had glyoxylate reductase activity 1.5 and 5.6% respectively of the wild type protein. Both mutant proteins were unstable on purification. Although there is wide expression of the GRHPR mRNA demonstrated by northern blot analysis, our study shows that GRHPR protein distribution is predominantly hepatic and concludes that PH2, like the related type 1 disease, is primarily a disorder affecting hepatic glyoxylate metabolism.
Copyright 2003 Wiley-Liss, Inc. Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Late diagnosis of primary hyperoxaluria type 2 in the adult: effect of a novel mutation in GRHPR gene on enzymatic activity and molecular modeling.J Urol. 2009 May;181(5):2146-51. doi: 10.1016/j.juro.2009.01.045. Epub 2009 Mar 17. J Urol. 2009. PMID: 19296982
-
Genetic basis of primary hyperoxaluria type II.Mol Urol. 2000 Winter;4(4):355-64. Mol Urol. 2000. PMID: 11156703
-
Three novel deletions in the alanine:glyoxylate aminotransferase gene of three patients with type 1 hyperoxaluria.Mol Genet Metab. 2001 Nov;74(3):314-21. doi: 10.1006/mgme.2001.3222. Mol Genet Metab. 2001. PMID: 11708860
-
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.Hum Mutat. 2009 Jun;30(6):910-7. doi: 10.1002/humu.21021. Hum Mutat. 2009. PMID: 19479957 Review.
-
Primary hyperoxaluria: genotype-phenotype correlation.J Nephrol. 2003 Mar-Apr;16(2):297-309. J Nephrol. 2003. PMID: 12768081 Review.
Cited by
-
Two novel AGXT mutations identified in primary hyperoxaluria type-1 and distinct morphological and structural difference in kidney stones.Sci Rep. 2016 Sep 20;6:33652. doi: 10.1038/srep33652. Sci Rep. 2016. PMID: 27644547 Free PMC article.
-
Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies.ACS Pharmacol Transl Sci. 2022 Sep 21;5(11):1007-1016. doi: 10.1021/acsptsci.2c00110. eCollection 2022 Nov 11. ACS Pharmacol Transl Sci. 2022. PMID: 36407951 Free PMC article. Review.
-
Molecular basis of primary hyperoxaluria: clues to innovative treatments.Urolithiasis. 2019 Feb;47(1):67-78. doi: 10.1007/s00240-018-1089-z. Epub 2018 Nov 14. Urolithiasis. 2019. PMID: 30430197 Review.
-
Identification of 8 novel gene variants in primary hyperoxaluria in 21 Chinese children with urinary stones.World J Urol. 2019 Aug;37(8):1713-1721. doi: 10.1007/s00345-018-2563-5. Epub 2018 Nov 28. World J Urol. 2019. PMID: 30488096
-
Clinical characteristics, genetic profile and short-term outcomes of children with primary hyperoxaluria type 2: a nationwide experience.Pediatr Nephrol. 2024 Apr;39(4):1093-1104. doi: 10.1007/s00467-023-06200-9. Epub 2023 Nov 2. Pediatr Nephrol. 2024. PMID: 37914965 Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical